David Badesch
Physician · University of Colorado School of Medicine
Credentials: · · · ·
History
Research
New England Journal of Medicine · 1996 · 2,085 citations
Bosentan therapy for pulmonary arterial hypertension
New England Journal of Medicine · 2002 · 2,012 citations
Sildenafil citrate therapy for pulmonary arterial hypertension
New England Journal of Medicine · 2005 · 1,796 citations
- AF
37 papers
- RB
37 papers
- VM
35 papers
- MG
32 papers
28 papers
- LR
26 papers
19 papers
18 papers
Grants
- 1997–2008
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $105.8K · University of Colorado Denver
- 2000–2006
Relative Arginine Deficiency in Pulmonary Hypertension
National Heart, Lung, and Blood Institute · K24
Contact PI · $616.9K · University of Colorado Denver
- 1990–1996
Hypertensive Pulmonary Vascular Remodeling--Role of Igf
National Heart, Lung, and Blood Institute · K08
Contact PI · $376.3K · University of Colorado Denver
Clinical trials
- 2011–2019
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Study chair · Completed · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
- 2006–2012
REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management
Study director · Completed
Actelion
- 2024–2028
Site PI · Recruiting · Phase 1, Phase 2
Novartis Pharmaceuticals
- 2015–2025
Pulmonary Hypertension Association Registry
Site PI · Recruiting
Pulmonary Hypertension Association, Inc.